10.1016/s1470-2045(16)30383-7 - 30-day mortality after systemic antic...

This document has been corrected

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study

10.1016/s1470-2045(16)30383-7

Published Online: 2016-09-?

Journal: The Lancet Oncology•Publisher: Elsevier BV

Authors: Charles Wilson•David Chao•David Dodwell•Denis Talbot•Emma B Saxon•Jem Rashbass•John Dewar•Martine Bomb•Matthew Wickenden•Michael Peake•Michael Wallington•Rebecca Smittenaar•Sean McPhail•Timothy Perren

This document has been corrected

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study

10.1016/s1470-2045(16)30383-7

Published Online: 2016-09-?

Journal: The Lancet Oncology

NOW

2016-10-01•Erratum

Correction to Lancet Oncol 2016; 17: 1203, 06, 08, 09, 11

10.1016/s1470-2045(16)30438-7

* information provided by CrossRef

2016-10-01•Erratum

10.1016/s1470-2045(16)30438-7

* information provided by CrossRef

2016-09-?•Published

2016-10-01•Erratum

Correction to Lancet Oncol 2016; 17: 1203, 06, 08, 09, 11

10.1016/s1470-2045(16)30438-7

* information provided by CrossRef

This document has been corrected

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study

10.1016/s1470-2045(16)30383-7

Published Online: 2016-09-?

Journal: The Lancet Oncology•Publisher: Elsevier BV